Medtide (HKSE:03880) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:03880 Medtide Inc HKSE:03880
23 GF Score
Price HK$21.22
View Full Analysis

What is Medtide Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

HKSE:03880 vs VRTX, REGN, MRNA: Short Interest Comparison

For the Biotechnology subindustry, Medtide's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medtide Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medtide's Short Interest distribution charts can be found below:

* The bar in red indicates where Medtide's Short Interest falls into.


HKSE:03880
23GF Score
Medtide Inc HKSE:03880
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtide Business Description

Other Exchanges FQ2:Germany
Address No. 69, 12 Street, Qiantang District, Zhejiang, Hangzhou, CHN
Medtide Inc offers full-cycle services ranging from early-stage discovery, preclinical research and clinical development to commercial-stage production. It mainly provide (i) CRO services, namely peptide NCE discovery synthesis; and (ii) CDMO services, namely peptide CMC development and commercial manufacturing. Its services focus on providing customers with APIs rather than drug products. Geographically, the company generates majority of its revenue from USA.
23GF Score

Get the complete analysis for HKSE:03880

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$21.22
Price